All Mergers and acquisitions articles – Page 7
-
BusinessCelgene and Jounce team up against cancer
Firms promise next-generation immuno-oncology as existing drugs rack up successes
-
Business
Henkel to buy detergent maker Sun Products
€3.2bn deal boosts Henkel’s position in North American laundry care market
-
Business
AstraZeneca licenses skin drugs to Leo
Offloading psoriasis and dermatitis antibodies continues AZ’s plan to refocus on fewer therapy areas
-
Business
Novartis partners with Xencor for cancer antibodies
Deal deepens Novartis’s focus on immuno-oncology
-
Business
Sanofi and Boehringer agree €11bn asset swap
Deal swaps Sanofi’s animal health arm for Boehringer’s consumer healthcare business as both firms aim to boost scale
-
Business
Teva sells off products in preparation for Allergan merger
Generics deals with Impax, Dr Reddy’s and Sagent aimed at satisfying competition authorities
-
Business
BASF boosts coatings with Chemetall buyout
$3.2bn purchase from Albemarle continues BASF’s efforts to expand and refocus its coatings division
-
Business
Westlake Chemical to buy rival Axiall
US chemical manufacturer Axiall acquired by Westlake Chemical for $3.8 billion, after its earlier bid was rejected
-
Business
Merck & Co to buy Afferent for neurology drugs
Deal worth up to $1.25bn includes drug candidate for chronic coughs
-
Business
J&J to buy Vogue for haircare range
$3.3bn deal expands Johnson & Johnson’s consumer products segment
-
Business
ThermoFisher Scientific to buy electron microscope maker
Deal will expand lab equipment provider’s instrument portfolio for life and materials sciences
-
Business
Jazz Pharma buy out Celator in $1.5bn deal
Deal centres on promising leukaemia drug fast-tracked by the US Food and Drug Administration
-
Business
US tax rules force fertiliser merger to fall flat
CF Industries’ $8bn merger plan to relocate from US to Europe scuppered by regulatory changes
-
Business
Monsanto turns down Bayer offer
As global agrochemical companies consolidate, Monsanto rejects ‘inadequate’ $62bn offer from Bayer
-
Business
Mylan expands in dermatology
$1bn deal with Renaissance Acquisition Holdings brings 25 products and builds on Meda merger portfolio
-
Business
Pfizer to buy Anacor for eczema ointment
$5.2bn deal will bolster pharma giant’s inflammation and immunology drugs portfolio
-
Business
Honeywell spins off resins and chemicals unit
‘AdvanSix’ will separate by early 2017 and produce nylon, fertiliser and various chemical intermediates
-
Business
Total to buy Saft for battery boost
€950m deal pushes French oil giant deeper into renewables
-
Business
Evonik acquires Air Products’ chemical unit
Air Products also spinning off electronic materials to focus on industrial gases
-
Business
Daiichi Sankyo awarded damages from former Ranbaxy owners
Arbitration says Singh family withheld information about regulatory investigations during Ranbaxy takeover
